TR200000133T2 - Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi. - Google Patents

Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.

Info

Publication number
TR200000133T2
TR200000133T2 TR2000/00133T TR200000133T TR200000133T2 TR 200000133 T2 TR200000133 T2 TR 200000133T2 TR 2000/00133 T TR2000/00133 T TR 2000/00133T TR 200000133 T TR200000133 T TR 200000133T TR 200000133 T2 TR200000133 T2 TR 200000133T2
Authority
TR
Turkey
Prior art keywords
diabetes
thiazolidinedione
diabetic
treatment
insulin secretagogue
Prior art date
Application number
TR2000/00133T
Other languages
English (en)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephen
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000133T2 publication Critical patent/TR200000133T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Etkili, toksik olmayan ve eczacilik teknolojisi bakimindan kabul edilebilir tutarda bir ensülin yönünden duyarli duruma getiricinin, bir insülin salgilattiricisinin bir alfa glükodinaz inhibitör (yasaklayici, engelleyici) antihiperglisemik etkenin, bunlara gereksinmesi bulunan bir memeliye verilmesini içeren diabetes mellitus'un ve memelide diabetes mellitus ile iliskili durumlarin tedavi edilmeleri için yöntem ile bu gibi yöntemin kullanilmasina yarar bilesim.
TR2000/00133T 1997-07-18 1998-07-16 Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi. TR200000133T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200000133T2 true TR200000133T2 (tr) 2000-09-21

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00133T TR200000133T2 (tr) 1997-07-18 1998-07-16 Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.

Country Status (27)

Country Link
EP (1) EP1001784A1 (tr)
JP (1) JP2001510160A (tr)
KR (1) KR20010021952A (tr)
CN (1) CN1263467A (tr)
AP (1) AP2000001735A0 (tr)
AR (2) AR016350A1 (tr)
AU (1) AU8449098A (tr)
BG (1) BG104062A (tr)
BR (1) BR9810292A (tr)
CA (1) CA2297133A1 (tr)
CO (1) CO4940489A1 (tr)
DZ (1) DZ2563A1 (tr)
EA (1) EA200000140A1 (tr)
GB (1) GB9715298D0 (tr)
HU (1) HUP0003626A3 (tr)
ID (1) ID23804A (tr)
IL (1) IL133907A0 (tr)
MA (1) MA24608A1 (tr)
NO (1) NO20000230L (tr)
OA (1) OA11312A (tr)
PE (1) PE99499A1 (tr)
PL (1) PL338140A1 (tr)
SK (1) SK612000A3 (tr)
TR (1) TR200000133T2 (tr)
UY (1) UY25101A1 (tr)
WO (1) WO1999003478A1 (tr)
ZA (1) ZA986364B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US6660716B1 (en) * 1999-06-21 2003-12-09 Eli Lilly And Company Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagon-like peptide-1 and agonists thereof
DK1248604T4 (da) * 2000-01-21 2012-05-21 Novartis Ag Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
US20030040490A1 (en) * 2000-02-24 2003-02-27 Yasuo Sugiyama Drugs containing combined active ingredients
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
CA2725833A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
GEP20084570B (en) 2003-10-31 2008-12-25 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69219136T2 (de) * 1991-08-26 1997-08-28 Pharmacia & Upjohn Co., Kalamazoo, Mich. Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
UY25101A1 (es) 2000-12-29
SK612000A3 (en) 2000-07-11
CA2297133A1 (en) 1999-01-28
KR20010021952A (ko) 2001-03-15
BG104062A (en) 2000-11-30
DZ2563A1 (fr) 2003-02-15
AP2000001735A0 (en) 2000-01-16
HUP0003626A3 (en) 2001-12-28
GB9715298D0 (en) 1997-09-24
HUP0003626A2 (hu) 2001-05-28
WO1999003478A1 (en) 1999-01-28
AU8449098A (en) 1999-02-10
PE99499A1 (es) 1999-12-18
PL338140A1 (en) 2000-09-25
NO20000230D0 (no) 2000-01-17
AR019724A2 (es) 2002-03-13
ID23804A (id) 2000-05-11
EA200000140A1 (ru) 2000-06-26
IL133907A0 (en) 2001-04-30
AR016350A1 (es) 2001-07-04
CN1263467A (zh) 2000-08-16
JP2001510160A (ja) 2001-07-31
MA24608A1 (fr) 1999-04-01
CO4940489A1 (es) 2000-07-24
OA11312A (en) 2003-10-24
BR9810292A (pt) 2000-09-19
NO20000230L (no) 2000-01-17
EP1001784A1 (en) 2000-05-24
ZA986364B (en) 2000-01-17

Similar Documents

Publication Publication Date Title
EA200000041A1 (ru) Способ лечения диабета тиазолидиндионом и метформином
TR200100773T2 (tr) Bir aP2 önleyicisinin ve kombinasyonunun kullanıldığı diyabet tedavi yöntemi
EA200300036A1 (ru) Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
NO970519L (no) Behandling av type II diabetes mellitus med amylinagonister
CY1105254T1 (el) Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο
EA200000042A1 (ru) Способ лечения диабета росиглитазоном и инсулином
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
GB2380939B (en) Treatment or prevention of auto-immune diseases
NO20000230L (no) Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor
NO996270L (no) Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor
TR200000135T2 (tr) Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
TR199903096T2 (tr) Diabetin tiazolidinedion ve sülfonilüre ile tedavisi.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
ES2166406T3 (es) Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.
ES2181923T3 (es) 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina.
ES2135353A1 (es) Utilizacion del 17beta-estradiol, sus analogos y derivados en el tratamiento de la diabetes mellitus y sus manifestaciones.
AU2002319381A1 (en) Use of antidiabetics for making a medicine with cicatrizing effect
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
HK1028551A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor